ClinicalTrials.Veeva

Menu

Effect of Aging on Haemostasis Parameters

H

Hopital Lariboisière

Status

Completed

Conditions

Aging

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Aging is an independent risk factor, without any clear explanation. The primary aim of the study is to depict the effect of aging on the coagulation fibrinolysis parameters and microparticles.

Full description

Patients older than 40, without any acute disease and not receiving any antiaggregant and anticoagulant therapy will be included in the study. Blood tests will be performed for coagulation, fibrinolysis and microparticles measurement.

Enrollment

100 estimated patients

Sex

All

Ages

40+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age <40 2 groups : 1 : no history of VTE 2 : history of VTE

Exclusion criteria

  • antiaggregant or anticoagulant therapy at curative dose
  • arterial or thrombotic event in the last month

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems